Related Experiment Video
Updated: Jul 23, 2025

Targeting the Rat's Small Bowel: Long-Term Infusion into the Superior Mesenteric Artery
Published on: April 8, 2021
Olmesartan-Induced Enteropathy: A Case Report
Dharmikkumar Jadvani1, Pinky Jha2, Meenu Singh3
1Internal Medicine, Byramjee Jeejeebhoy (BJ) Medical College, Ahmedabad, IND.
Abstract:
Patients with olmesartan-induced enteropathy, a rare illness, frequently endure prolonged diarrhea and weight loss with no apparent cause. Because this adverse event's clinical and histological characteristics mimic those of other small intestine illnesses, it can be challenging to recognize it in a timely manner. We report a case of olmesartan-induced enteropathy in a 58-year-old male who had been on olmesartan for several years. Recently, during his travel to Greece, he developed diarrhea lasting several weeks. This was accompanied by a significant weight loss of 35 lbs, acute kidney injury, and hypokalemia. Extensive negative workup, including esophagogastroduodenoscopy (EGD) with normal biopsy of esophagus, stomach, duodenum, and terminal ileum, and colonoscopy with biopsies, autoimmune serologies, and infectious disease workup, led to a diagnosis of olmesartan-induced enteropathy as a diagnosis of exclusion. Diarrhea improved/resolved within a few days after stopping olmesartan in our patient.
Insights
Olmesartan-induced enteropathy causes unexplained diarrhea and weight loss. Discontinuing olmesartan medication rapidly resolved symptoms in a patient, highlighting its importance in diagnosis.
Area of Science:
- Gastroenterology
- Internal Medicine
- Pharmacology
Background:
- Olmesartan-induced enteropathy is a rare adverse drug reaction.
- It presents with chronic diarrhea and weight loss, mimicking other small intestine diseases.
- Timely diagnosis is often challenging due to overlapping clinical and histological features.
Observation:
- A 58-year-old male on long-term olmesartan developed severe diarrhea, weight loss (35 lbs), acute kidney injury, and hypokalemia.
- Extensive investigations including upper and lower endoscopy with biopsies, autoimmune markers, and infectious disease workup were negative.
- Symptoms emerged during travel, suggesting a potential environmental or drug-related trigger.
Findings:
- Olmesartan-induced enteropathy was diagnosed as a diagnosis of exclusion.
- Discontinuation of olmesartan led to rapid improvement and resolution of diarrhea within days.
- This case underscores the gastrointestinal side effects of olmesartan.
Implications:
- Early recognition and drug withdrawal are crucial for managing olmesartan-induced enteropathy.
- Physicians should consider this diagnosis in patients with unexplained chronic diarrhea on olmesartan.
- Further research into the pathogenesis and diagnostic markers is warranted.
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Drugs for Treatment of Ulcerative Colitis in IBD
Antihypertensive Drugs: Potassium-Sparing Diuretics
Nephrotic Syndrome II : Assessment and Medical Management
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...

